Home › Funds › Vivo Capital, LLC › JSPR

Vivo Capital, LLC position in JSPR

Jasper Therapeutics Inc · Health Care

Vivo Capital, LLC reported holding 5,364 shares of JSPR (Jasper Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$4K, representing 0.00% of its reported portfolio and ranking #49 among its reported holdings. Vivo Capital, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)5.36K sh
Reported value held$3.69K
Portfolio Weight0.00%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's JSPR position evolved

Vivo Capital, LLC first disclosed a stake in JSPR in Q3 2026 at 5,364 shares (US$4K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 5.36K $3.69K New

About JSPR and 13F data

JSPR (Jasper Therapeutics Inc) is a Health Care company. 7 other funds we track also report a position in JSPR — the largest reported positions include Velan Capital Investment Management LP (US$1.1M), Carlyle Group Inc. (US$618K), ACORN CAPITAL ADVISORS, LLC (US$604K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JSPR

All JSPR fund holders →

FAQ

How long has Vivo Capital, LLC held JSPR?

Vivo Capital, LLC has disclosed JSPR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in JSPR?

As of Q3 2026, Vivo Capital, LLC holds 5.36K shares of JSPR (Jasper Therapeutics Inc), valued at $3.69K, representing 0.00% of its reported portfolio and ranking #49.

Has Vivo Capital, LLC been buying or selling JSPR?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in JSPR.

Which other funds hold JSPR?

Other major institutional holders of JSPR include Velan Capital Investment Management LP, Carlyle Group Inc., ACORN CAPITAL ADVISORS, LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.